With many viruses now on the rise, it can be hard to know which illness you have and how to handle it. A doctor helps you to ...

Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...

Invivyd Inc. (NASDAQ:IVVD) announced that new in vitro neutralization data show continued neutralizing activity of Pemgarda ...

COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disability.

It's hard to believe it's been five years since the start of COVID-19. This timeline serves as a reminder of those early days ...

Donald Trump reportedly intends to seal off the US-Mexican border by invoking a public health emergency. The ...

Study uncovers the evolution, transmission, and geographic spread of bat coronaviruses in China, revealing key insights into ...

The COVID pandemic is ongoing, but scientists are on alert for any pathogen that might lead to another global outbreak of ...

If you’ve been hit with a respiratory tract infection this festive season, it’s more likely to be Covid-19 than the flu.

After a relatively slow start to the respiratory virus season, Covid-19 levels in the United States began ramping up just ...

The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...

Simaravibart is under clinical development by Contraria Biotech and currently in Phase III for Coronavirus Disease 2019 (COVID-19).